2025 annual financial data
Lakewood-Amedex Biotherapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -3,772,370 USD and net income was -3,847,637 USD.
Operating cash flow was -1,944,698 USD.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,772,370 USD
- Net income
- -3,847,637 USD
- Operating cash flow
- -1,944,698 USD